Skip to main content
Teriflunomide – Healthcare professional (HCP)
For Healthcare Professionals
Teriflunomide – Healthcare professional (HCP) – Education / Discussion Guide - Risk Minimisation Information for Healthcare Professionals
Back to top
Risk Minimisation Materials
Search by company, common medicine name, or title of Risk Minimisation Material
Teriflunomide
Amarox Limited
For Healthcare Professionals
Teriflunomide – Patient Card
Teriflunomide – Patient Card - Risk Minimisation Information for Patients
axunio Pharma GmbH
Teriflunomide Healthcare Professional Education/Discussion Guide
For Healthcare Professionals
At first prescription, the prescriber/healthcare professional (HCP) should discuss with the patient the risks described within the discussion guide. The guide is aimed at increasing awareness about the potential risk of haematological effects and liver effects, risk of hypertension, serious infections and teratogenicity with teriflunomide and providing guidance on how to manage that risk. For hard copies of this information, please contact axunio Pharma directly via email to [email protected].
Teriflunomide Patient Card
This patient card provides important information on the risks
of teriflunomide. At first prescription, the prescriber should provide this card. Please show this card to any doctor or
healthcare professional involved in your medical care
(e.g., in case of an emergency). For hard copies, please contact axunio Pharma via email to [email protected].
Dr. Reddy's Laboratories (UK) Ltd
Dr. Reddy's Teriflunomide HCP Guide
For Healthcare Professionals
HEALTHCARE PROFESSIONAL EDUCATION/DISCUSSION GUIDE.
MSN Laboratories Europe Ltd
Healthcare Professional Education/Discussion Guide - Teriflunomide
For Healthcare Professionals
HCP guide
Mylan
TERIFLUNOMIDE MYLAN HEALTHCARE PROFESSIONAL EDUCATION/DISCUSSION GUIDE
For Healthcare Professionals
Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.
TERIFLUNOMIDE MYLAN PATIENT CARD
Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.
Sandoz Limited
Teriflunomide Sandoz 14 mg Film-coated Tablets - Healthcare Professional Guide
For Healthcare Professionals
Provides guidance to HCPs on the risks associated with teriflunomide and explains that patients should be regularly consulted about these risks. Potential risks are described as are monitoring methods. Risk of teratogenicity is described and that teriflunomide is contraindicated in pregnancy. Specific guidance on this subject is also offered.
Teriflunomide Sandoz 14mg Film-coated Tablets - Patient Alert Card
This patient alert card provides important information to patients, on the risks of using teriflunomide. This includes a warning that teriflunomide should not be used during pregnancy and offers further guidance on this subject to women who are using teriflunomide.
You are trying to reach document intended for healthcare professionals only.
Are you a healthcare professional?
